Response to comment - Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology
- PMID: 34579986
- DOI: 10.1016/j.ejca.2021.08.043
Response to comment - Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology
Conflict of interest statement
Conflict of interest statement The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: A.Z.: received travel support from Novartis, Sanofi Grenzyme, and Bristol-Myers Squibb, outside the submitted work. D.S: reports grants and other from BMS, personal fees from BMS, during the conduct of the study; personal fees from Amgen, personal fees from Boehringer Ingelheim, personal fees from InFlarX, personal fees and other from Roche, grants, personal fees and other from Novartis, personal fees from Incyte, personal fees and other from Regeneron, personal fees from 4SC, personal fees from Sanofi, personal fees from Neracare, personal fees from Pierre Fabre, personal fees and other from Merck-EMD, personal fees from Pfizer, personal fees and other from Philiogen, personal fees from Array, personal fees and other from MSD, outside the submitted work. E.H. and K.G.: No relevant conflicts of interest.
Comment on
-
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology.Eur J Cancer. 2021 May;148:340-347. doi: 10.1016/j.ejca.2021.02.025. Epub 2021 Mar 25. Eur J Cancer. 2021. PMID: 33773277 Free PMC article.
-
Re: Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology: Melanocytic tumours with Spitz-like morphology: toward a therapy-oriented diagnostic approach.Eur J Cancer. 2021 Nov;157:511-513. doi: 10.1016/j.ejca.2021.06.045. Epub 2021 Aug 10. Eur J Cancer. 2021. PMID: 34389197 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical